mynth
11/2020100%

Vidacura acquired by Apheon

GERMANY Health Providers / Healthcare Facilities / Nursing Homes REV 1m EUR - 100m EUR

Context

Ergon Capital, acting through its acquisition vehicle SCUR-Alpha 1227 GmbH, acquired 100% of VidaCura's inpatient and ambulatory nursing care operations following clearance from the German Federal Cartel Office (Bundeskartellamt) on November 26, 2020. The transaction represents the largest single healthcare deal in Germany in 2020 by number of care places. The deal adds 3,421 care places across 37 nursing homes and assisted living facilities to Ergon Capital's German healthcare portfolio, complementing its existing investment in out-of-hospital intensive care operator opseo.

Vidacura, which reported an EBITDA margin of [members only] in 2020, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average observed in the Healthcare & Pharma sector (14.6x in 2020).

-> Deep-dive in Healthcare & Pharma market trends

Target

VidaCura is a fast-growing German nursing home operator, ranking among the Top 30 care home operators in Germany in 2021. The group operates nursing homes and assisted living facilities, primarily concentrated in Bavaria and North Rhine-Westphalia — Germany's two most populous federal states — with additional presence in Hesse, Rhineland-Palatinate, Lower Saxony, and Baden-Württemberg (via the Claudius Schrenk Group assisted living facility).

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2020
€1–100M
[members only]
[members only]
2019
€1–100M
[members only]
[members only]

Other operations with Apheon

Other operations with Apheon
DateAcquirerTargetCountrySector
10/2026APHEONHAGER & MEISINGERGERMANYMedical Consumables
07/2026APHEONTEKNIMEDFRANCEImplants & Prosthetics
07/2026APHEONALMAFRANCEFood Products
11/2024APHEON / GROUPE LFPIHAUDECOEURFRANCEFood Retail
12/2020APHEONMILLBO BIONATURALS GROUPITALYIngredients
06/2019APHEONHAUDECOEURFRANCEFood Retail
04/2016APHEON / BPIFRANCELOOPING GROUPFRANCELeisure Facilities
05/2015APHEONGOLDEN GOOSEITALYFashion & Apparel

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
12/2020MEDIAN KLINIKENPRIORY GROUPUNITED KINGDOMClinics / Hospitals
12/2020ANTIN INFRASTRUCTUREHIPPOCRATES (LAF - LA FARMACIA)ITALYPharmacy
11/2020L CATTERTONALLIANCE ANIMAL HEALTHUNITED STATESVet Clinics
11/2020MEDICA GROUPGLOBAL DIAGNOSTICSIRELANDRadiology
11/2020DWS GROUPMEDIPASSITALYRadiology
11/2020ARDIANINOVIE GROUPFRANCELabs (Biology)
10/2020KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERSELSANFRANCEClinics / Hospitals
10/2020THE VISTRIA GROUP / CENTERBRIDGE PARTNERSHELP AT HOMEUNITED STATESNursing Homes
10/2020INFRATILQSCAN GROUPAUSTRALIARadiology
09/2020VAM INVESTMENTSDEMENEGOITALYOphthalmology

REFERENCES

Revenue range: REV 1m EUR - 100m EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Vidacura by Apheon are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: apheon

FAQ

What transaction does this page cover?

This page covers Apheon’s acquisition of 100% of Vidacura, a German company specialised in Healthcare Facilities, in 2020.

How does the valuation of Vidacura compare to benchmarks in the Healthcare & Pharma sector?

Transaction multiples for this specific deal are exclusively reserved for mynth members. Nevertheless, transactions tracked by mynth in this sector reveal an average benchmark multiple of 14.6x EBITDA during 2020.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.